Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0186-2020Class II

Torrent Suite Dx Software Version (IUO) 5.4 Catalog Number: A31774 OEM Customer Software: Sentosa SQ Suite...

Life Technologies Holdings Pte Ltd. / initiated 2019-09-26 / Terminated / root cause: software

Life Technologies Holdings Pte Ltd began a recall of Torrent Suite Dx Software Version (IUO) 5.4 Catalog Number: A31774 OEM Customer Software: Sentosa SQ Suite Software v5.6.15 on . FDA classified it as Class II and gives the reason as "Torrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is detected at the same locus as a specified...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0186-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Life Technologies Holdings Pte Ltd.
Product
Torrent Suite Dx Software Version (IUO) 5.4 Catalog Number: A31774 OEM Customer Software: Sentosa SQ Suite Software v5.6.15
Product code
PFF High Throughput Dna Sequence Analyzer
Reason for recall
Torrent SuiteTM Dx analysis software, a component of the Ion PGM Dx Instrument System, incorrectly displays a positive result when a different analytical or de novo variant is detected at the same locus as a specified clinical variant
Root cause tag
software
FDA root cause
Software design
Action
1. Notify all PGM Dx users in your facility of this issue. 2. Require that the Test_Report.pdf file be used for reporting results for all future sample tests. 3. Require that the Test_Report.pdf file be used to confirm ALL positive call results. For sample result reporting that use the Test_Report.pdf file and NOT the Target_Summary.tab file, the results are valid, and no further action is needed. For sample result reporting that use the Target_Summary.tab file on the Torrent SuiteTM Dx software versions indicated above, customers MUST review ALL results obtained using the Target_Summary.tab file against the results shown in the Test_Report.pdf file to identify any occurrences of possible false positive reporting. 4. If you have shared reports using results from the Target_Summary.tab file, outside of your facility, you MUST notify those customers or facilities to take the required action. 5. Please complete the following Customer Response Sheet and submit sheet, along with this letter, by emailing a scanned copy to [email protected]. If you have any technical questions or concerns, please contact Technical Support at 800-955-6288 option 4 or [email protected]
Quantity in commerce
total of Ion+vela +chassis =400 units
Distribution
states : AZ, CA, CO, CT, FL, GA, IN, MA, MD, NC, NJ, NM, NY, OR, TX, VA, WA OUS: South Korea, ITALY, China, Japan, Singapore, Germany, TAIWAN, Poland
Product codes and lots
The field action is associated with the software available on the PGM Dx instrument, therefore no lot code is applicable for this part type

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0186-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0185-2020Class IITerminatedVoluntary: Firm initiated
Z-0186-2020Class IITerminatedVoluntary: Firm initiated
Z-0187-2020Class IITerminatedVoluntary: Firm initiated
Z-0188-2020Class IITerminatedVoluntary: Firm initiated